Changes in insulin sensitivity induced by short-term growth hormone (GH) and insulin-like growth factor I (IGF-I) treatment in GH-deficient adults are not associated with changes in adiponectin levels
Persistent headaches are not typical and could indicate issues with peptide purity, dosing errors, or unrelated medical conditions that coincidentally appeared during use
You become an informed patient, ready to make the best decision for your health and wallet
Considerations Human data is limited, with most evidence from animal studies and user reports
Researchers investigating hair follicles, scalp biology, and tissue health often explore peptides that may influence cellular signaling pathways
Whether the FDA ultimately recommends adding these peptides to a bulks list or not, this week's meeting should prompt a broader conversation